| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | WZ8040 | CTRPv2 | pan-cancer | AAC | -0.0017 | 1 |
| mRNA | TG-101348 | GDSC1000 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | selumetinib:GDC-0941 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | BRD-K37390332 | CTRPv2 | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | -0.001 | 1 |
| mRNA | NVP-BEZ235 | CTRPv2 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | IPA-3 | GDSC1000 | pan-cancer | AAC | 0.00097 | 1 |
| mRNA | CAY10603 | GDSC1000 | pan-cancer | AAC | -0.00085 | 1 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | 0.00098 | 1 |
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | 0.0012 | 1 |